HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Cosmetic Products Safe From BSE-Infected Cow – FDA

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics manufactured in the U.S. are highly unlikely to be contaminated by rendered products from the cow in Washington state that tested positive for bovine spongiform encephalopathy last month, according to FDA

You may also be interested in...



China To Resume U.S. Cosmetic Imports Based On Certification

China will resume importing cosmetics from the U.S. provided they include export certificates demonstrating the products do not contain animal-related ingredients prohibited in China, FDA announced April 21

China To Resume U.S. Cosmetic Imports Based On Certification

China will resume importing cosmetics from the U.S. provided they include export certificates demonstrating the products do not contain animal-related ingredients prohibited in China, FDA announced April 21

CTFA To Seek Clarity On Wrinkle Product Regulatory Status, BSE Rule

The Cosmetic, Toiletry and Fragrance Association will likely submit a legal memorandum to FDA later this month supporting exclusion of wrinkle removers containing alpha hydroxy and beta hydroxy acids from OTC review, according to President Ed Kavanaugh

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel